Emma Guttman, MD, PhD
- PROFESSOR | Dermatology
- PROFESSOR | Medicine, Clinical Immunology
Dr. Emma Guttman-Yassky is the Sol and Clara Kest Professor and Vice Chair for Research at the Department of Dermatology, Director of the Center for Excellence in Eczema, and Director of the Laboratory of Inflammatory Skin Diseases at the Icahn School of Medicine at Mount Sinai Medical Center, New York. She earned her MD from Sackler in Tel-Aviv, and a PhD. from Bar-Ilan, Israel. After her Israeli Board certification in dermatology at the Rambam Medical Center at the Technion, Dr. Guttman moved to the U.S. to pursue a postdoctoral fellowship at Laboratory for Investigative Dermatology at The Rockefeller University and a second dermatology residency training at Weill-Cornell, NY, being uniquely board certified in dermatology both in the US and Israel.
Dr. Guttman’s major clinical and research area of expertise is inflammatory skin diseases with major focus on atopic dermatitis or eczema and alopecia areata, as well as other inflammatory skin diseases. She made paradigm-shifting discoveries on the immunologic basis of AD/eczema in humans, opening the door to new therapeutics. Dr. Guttman has developed the only comprehensive molecular maps of AD, defining skin differentiation and immune-circuits characterizing this disease. She has established the reversibility of the AD phenotype and defined a series of biomarkers that are now accelerating testing of novel pathway-specific drugs for AD. Her research on atopic dermatitis/eczema has contributed directly to many of the recently developed treatments for this disease, earning her a unique place as one of the leaders in dermatology and immunology worldwide. She has also shown that Atopic dermatitis is a complex disease with distinct phenotypes based on ethnicity, age and other factors. She has shown that atopic dermatitis in Asian and African American patients is different from atopic dermatitis in European American patients, with important therapeutic implications. She is now testing (both clinically and mechanistically) multiple targeted-therapeutics for atopic dermatitis. She has recently also extended her research interest to alopecia areata in which her findings are also translated to novel therapeutic targets. She has co-founded the international eczema council/IEC, for which she functions as president. This organization now comprises of the vast majority of top experts in atopic dermatitis/eczema worldwide. She is also on the scientific advisory board of the national eczema association. She was elected to the American Society for Clinical Investigation/ASCI, the American Dermatological Society/ADA, and received the Young Investigator Award (2011) from the AAD, as well as other awards. She has also been elected to serve on the board of the American Skin Association.
Dr. Guttman is considered one of the world’s leading experts in inflammatory skin diseases and authored more than 150 articles and is often invited as a keynote speaker to multiple international and national meetings. Her achievements have been numerously highlighted by the media including the New York Times, ABC news, CBS news, Daily news, Reuters, wall street journal, NY1, and others.
Dr. Guttman divides her time between a busy clinic, where she sees patients from all over the US and the world, that are coming to seek her advise in treating inflammatory skin diseases, and her growing laboratory that focuses on research on the mechanisms underlying inflammatory skin diseases, leading to novel treatments for these patients.
American Board of Dermatology
Multi-Disciplinary Training AreaImmunology [IMM]
MD, Sackler School of Medicine
Internship, Rotating, Meir Hospital
Residency, Dermatology, Rambam Health Care Campus
Internship, Internal Medicine, Memorial Sloan-Kettering Cancer Center
Residency, Dermatology, Weill Cornell Medical College
Young Investigator Award (2011)
Inflammatory Skin Diseases
Dr. Guttman’s groundbreaking research focuses on atopic dermatitis/eczema and contact dermatitis. Her research has important implications in advancing the current molecular knowledge on atopic dermatitis/eczema and developing new therapeutics.
Dr. Guttman currently develops biomarkers of atopic dermatitis that could be used for future studies with targeted therapeutics. She also concentrates on unraveling the primary pathogenesis of this common disease.
She is the recipient of the prestigious Young Investigator Award (2011) from the of Dermatology, the 2011 recipient of the Dermatology Foundation’s Physician-Scientist Career Development Award, and the recipient of the Fisher award of the American Contact Dermatitis Society 2011.